z-logo
open-access-imgOpen Access
Heavy Alcohol Use is Associated with Lower CD4 Counts among Russian Women Living with HIV: A Multilevel Analysis
Author(s) -
Ariadna Capasso,
Jennifer L. Brown,
Polina Safonova,
N. А. Belyakov,
В. В. Рассохин,
Ralph J. DiClemente
Publication year - 2021
Publication title -
aids and behavior
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.994
H-Index - 106
eISSN - 1573-3254
pISSN - 1090-7165
DOI - 10.1007/s10461-021-03270-4
Subject(s) - health psychology , phosphatidylethanol , heavy drinking , medicine , psychological intervention , human immunodeficiency virus (hiv) , viral load , public health , alcohol , demography , environmental health , immunology , psychiatry , poison control , injury prevention , chemistry , phospholipid , biochemistry , nursing , membrane , phosphatidylcholine , sociology
Alcohol use remains prevalent among Russian women with HIV infection. Multilevel mixed effects models were used to estimate the association of heavy drinking and HIV outcomes among women (N = 250 at baseline; N = 207 at follow-up), aged 18-35, engaged in HIV care in Saint Petersburg. Alcohol use was assessed at baseline and 3 months by self-report and by the biomarker phosphatidylethanol (PEth). Overall, 35% of women were heavy drinkers, defined as women reporting ≥ 1 past-30-day heavy drinking episode (≥ 4 standard drinks on one occasion) or with PEth blood levels ≥ 80 ng/mL. Women who engaged in heavy drinking had an average 41 CD4 cells/mm 3 (95% CI = - 81, - 2; z = - 2.04; P = 0.042) fewer than those who did not. Heavy drinking was associated with higher HIV symptom burden (IRR = 1.20; 95% CI = 1.05, 1.36; z = 2.73; P = 0.006) and suboptimal antiretroviral adherence (OR = 3.04; 95% CI = 1.27, 7.28; χ 2  = 2.50; P = 0.013), but not with viral load. Findings support the integration of alcohol treatment interventions as part of routine HIV care in Russia.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here